Skip to main content
Clinical Trials/EUCTR2017-004986-28-AT
EUCTR2017-004986-28-AT
Active, not recruiting
Phase 1

Effect of systemic antibiotic therapy on postoperative complications in patients undergoing wisdom teeth removal surgery. A double-blind, randomised, placebo-controlled Trial - AMOXI

Medizinische Universität Graz, Klin. Abteilung für Orale Chirurgie und Kieferorthopädie0 sites59 target enrollmentFebruary 8, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Surgical extraction of third molars
Sponsor
Medizinische Universität Graz, Klin. Abteilung für Orale Chirurgie und Kieferorthopädie
Enrollment
59
Status
Active, not recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 8, 2019
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
Medizinische Universität Graz, Klin. Abteilung für Orale Chirurgie und Kieferorthopädie

Eligibility Criteria

Inclusion Criteria

  • \-Symptom\-free, bilaterally located third molars
  • \-Medically healthy patient \= 16 years
  • \- No allergies/intolerances against the investigational product/placebo
  • \- Informed consent
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 20
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 34
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 5

Exclusion Criteria

  • \-General contraindications to wisdom tooth extraction surgery
  • \-(Former) heavy smoking
  • \-Use of antibiotics within the last three months or patients requiring antiobiotic treatment prior to surgery
  • \-(Planned) Pregnancy/lactating

Outcomes

Primary Outcomes

Not specified

Similar Trials